In the present study, we investigated whether the selective inhibition of CD36 could exert the direct antitumor effect and the immunomodulatory effects in OSCCs to elucidate the role of CD36-mediated lipid metabolism in OSCC tumor-bearing hosts. This evidence concerns the gene CD36 and neoplasm.